证券记录 · 已归档季度
HRMY
Harmony Biosciences Holdings, Inc. · Healthcare · Biotechnology
14被追踪持有人
-1Δ持有人
7.61M持有股份
$261.77M报告持仓市值
+0新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 -6.7% ·
股份流向 +30.0% ·
净新建仓位 -7.1%
— 公式
集中积累 — 持股数量上升但持有人减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q4 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 113 | +5 | 37.66M | $1.37B | +12 | −6 |
| Q1 2026 | 110 | -3 | 39.20M | $1.10B | +5 | −9 |
| Q4 2025 | 114 | +1 | 39.01M | $1.46B | +2 | — |
| Q3 2025 | 20 | +1 | 24.69M | $680.58M | +2 | −2 |
| Q2 2025 | 17 | -1 | 23.07M | $729.13M | +1 | −2 |
| Q1 2025 | 15 | +1 | 6.74M | $223.55M | +1 | — |
| Q4 2024 | 14 | -1 | 7.61M | $261.77M | — | −1 |
| Q3 2024 | 14 | +1 | 3.56M | $142.57M | +1 | — |
| Q2 2024 | 13 | — | 3.50M | $105.70M | — | — |
持有人 · Q4 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (被动) | 1.58M | — | $54.40M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Citadel Advisors ✦ | 1.37M | +784.6% | $47.08M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | Citadel Advisors ✦ | 1.37M | +784.6% | $47.08M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Marshall Wace ✦ | 929.74K | +165.2% | $31.99M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Marshall Wace ✦ | 929.74K | +165.2% | $31.99M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Geode Capital Management ✦ (被动) | 902.93K | +22.8% | $31.08M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | Geode Capital Management ✦ (被动) | 902.93K | +22.8% | $31.08M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | Renaissance Technologies ✦ | 568.67K | +15.4% | $19.57M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | Adage Capital Partners ✦ | 500.00K | +66.7% | $17.20M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | D. E. Shaw & Co. ✦ | 480.61K | +35.0% | $16.54M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | D. E. Shaw & Co. ✦ | 480.61K | +35.0% | $16.54M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | Norges Bank ✦ (被动) | 468.41K | +16.1% | $16.12M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Arrowstreet Capital ✦ | 296.62K | -6.6% | $10.21M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | Two Sigma Investments ✦ | 275.59K | +92.7% | $9.48M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 158.86K | +11.4% | $5.47M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 158.86K | +11.4% | $5.47M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 158.86K | +11.4% | $5.47M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 18 | Gotham Asset Management ✦ | 50.50K | -24.3% | $1.74M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | T. Rowe Price ✦ | 19.79K | +33.0% | $681,000 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 20 | Millennium Management ✦ | 6.33K | -91.1% | $217,919 | 0.0% | ▼ Trim | 3 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Wellington Management | $625,680 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 306 持有人, 54.70M 股份, $1.38B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q4 2024 ·
方法论 ·
通过API获取此数据